Date of submission of the HTAC Recommendation: 13 February 2026Date of notification to HTAC on the SOH decision: 02 June 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on multiple micronutrient supplement (MMS) film-coated tablet for the prevention of vitamin and mineral deficiencies, improvement of iron status, and continue reading : HTA Council Final Recommendation on Multiple Micronutrient Supplement (MMS) film-coated tablet for the prevention of vitamin and mineral deficiencies, improvement of iron status, and reduction of anemia among pregnant and lactating women (with Secretary of Health Decision)
HTA Council Final Recommendation on gadobutrol (1) 1.0 mmol/mL solution for intravenous (IV) injection, 7.5 mL, in a clear colorless glass vial and (2) 1.0 mmol/mL solution for IV injection, 7.5 mL in a type 1 colorless glass pre-filled syringe (PFS) for use in diagnostic magnetic resonance imaging (MRI) in adults and children (with Secretary of Health Decision)
Date of submission of the HTAC Recommendation: 11 June 2026Date of notification to HTAC on the SOH decision: 20 July 2026 The Secretary of Health (SOH) concurs with the final recommendation of the HTA Council on gadobutrol (1) 1.0 mmol/mL solution for intravenous (IV) injection, 7.5 mL, in a clear colorless glass vial and (2) 1.0 continue reading : HTA Council Final Recommendation on gadobutrol (1) 1.0 mmol/mL solution for intravenous (IV) injection, 7.5 mL, in a clear colorless glass vial and (2) 1.0 mmol/mL solution for IV injection, 7.5 mL in a type 1 colorless glass pre-filled syringe (PFS) for use in diagnostic magnetic resonance imaging (MRI) in adults and children (with Secretary of Health Decision)